Table 1.

Clinical and hormonal characteristics in the group of patients who restarted treatment (group A) and in those who remained without treatment (group B) at diagnosis and at baseline.

	Diagnosis							Baseline
	Age (years)	TSH (U/L)	fT4 (pg/mL) (nv 9–17)	TPOAb (U/mL) (nv <34)	TGAb (U/mL) (nv <115)	Goiter (%)	Puberty (%)	Age (years)	TPOAb U/mL)	TGAb (U/mL)	CXCL110 (#32)	Goiter (%)	TS	Puberty (%)
Group A (#62)	9.67 ± 2.65	67.06 ± 177.2	9.06 ± 3.66	1226 ± 2566	746 ± 976	46.3	46.3	13.06 ± 3.05	698 ± 889	583 ± 934	134.39 ± 62.98	66.6	2.52 ± 1.23	75
Group B (#78)	11.01 ± 2.37	14.59 ± 14.14	9.98 ± 2.99	656 ± 1118	465 ± 637	46	58.7	15.1 ± 2.15	366 ± 402	365 ± 606	106.1 ± 43.7	28.2	2.36 ± 1.12	92.8
P	<0.05	<0.05	NS	NS	<0.05	NS	NS	<0.05	<0.005	NS	NS	<0.05	NS	NS